Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Origin of magnetic properties in carbon implanted ZnO nanowires.

Wang YF, Shao YC, Hsieh SH, Chang YK, Yeh PH, Hsueh HC, Chiou JW, Wang HT, Ray SC, Tsai HM, Pao CW, Chen CH, Lin HJ, Lee JF, Wu CT, Wu JJ, Chang YM, Asokan K, Chae KH, Ohigashi T, Takagi Y, Yokoyama T, Kosugi N, Pong WF.

Sci Rep. 2018 May 17;8(1):7758. doi: 10.1038/s41598-018-25948-x.

2.

Rapid and sensitive detection of viral nucleic acids using silicon microchips.

Powell L, Wiederkehr RS, Damascus P, Fauvart M, Buja F, Stakenborg T, Ray SC, Fiorini P, Osburn WO.

Analyst. 2018 May 29;143(11):2596-2603. doi: 10.1039/c8an00552d.

PMID:
29741175
3.

Oral NaHCO3 Activates a Splenic Anti-Inflammatory Pathway: Evidence That Cholinergic Signals Are Transmitted via Mesothelial Cells.

Ray SC, Baban B, Tucker MA, Seaton AJ, Chang KC, Mannon EC, Sun J, Patel B, Wilson K, Musall JB, Ocasio H, Irsik D, Filosa JA, Sullivan JC, Marshall B, Harris RA, O'Connor PM.

J Immunol. 2018 May 15;200(10):3568-3586. doi: 10.4049/jimmunol.1701605. Epub 2018 Apr 16.

PMID:
29661827
4.

Sodium bicarbonate loading limits tubular cast formation independent of glomerular injury and proteinuria in dahl salt-sensitive rats.

Ray SC, Patel B, Irsik DL, Sun J, Ocasio H, Crislip GR, Jin CH, Chen JK, Baban B, Polichnowski AJ, O'Connor PM.

Clin Sci (Lond). 2018 Apr 12. pii: CS20171630. doi: 10.1042/CS20171630. [Epub ahead of print]

PMID:
29650676
5.

Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition.

Ray SC, Rappleye CA.

Semin Cell Dev Biol. 2018 Mar 21. pii: S1084-9521(17)30206-9. doi: 10.1016/j.semcdb.2018.03.009. [Epub ahead of print] Review.

PMID:
29551572
6.

Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane.

Wang Z, Gurule EE, Brennan TP, Gerold JM, Kwon KJ, Hosmane NN, Kumar MR, Beg SA, Capoferri AA, Ray SC, Ho YC, Hill AL, Siliciano JD, Siliciano RF.

Proc Natl Acad Sci U S A. 2018 Mar 13;115(11):E2575-E2584. doi: 10.1073/pnas.1720665115. Epub 2018 Feb 26.

PMID:
29483265
7.

Facile Synthesis of Nitrogen Doped Graphene Oxide from Graphite Flakes and Powders: A Comparison of Their Surface Chemistry.

Yokwana K, Ray SC, Khenfouch M, Kuvarega AT, Mamba BB, Mhlanga SD, Nxumalo EN.

J Nanosci Nanotechnol. 2018 Aug 1;18(8):5470-5484. doi: 10.1166/jnn.2018.15429.

PMID:
29458600
8.

Conduction Mechanisms in Polyvinyl Alcohol: CdS/CdS:Cu Nanoparticle Hybrid Nanocomposites.

Sarma S, Mothudi BM, Dhlamini MS, Ray SC.

J Nanosci Nanotechnol. 2018 Feb 1;18(2):1369-1375. doi: 10.1166/jnn.2018.15208.

PMID:
29448594
9.

Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.

Mankowski MC, Kinchen VJ, Wasilewski LN, Flyak AI, Ray SC, Crowe JE Jr, Bailey JR.

Proc Natl Acad Sci U S A. 2018 Jan 2;115(1):E82-E91. doi: 10.1073/pnas.1718441115. Epub 2017 Dec 18.

PMID:
29255018
10.

Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population.

Rose R, Lamers SL, Massaccesi G, Osburn W, Ray SC, Thomas DL, Cox AL, Laeyendecker O.

Infect Genet Evol. 2018 Mar;58:77-82. doi: 10.1016/j.meegid.2017.12.015. Epub 2017 Dec 16.

PMID:
29253674
11.

Facilitators and barriers to effective primary health care in Zimbabwe.

Ray SC, Masuka N.

Afr J Prim Health Care Fam Med. 2017 Nov 28;9(1):e1-e2. doi: 10.4102/phcfm.v9i1.1639. Review.

12.

Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1).

Williamson DS, Smith GP, Acheson-Dossang P, Bedford ST, Chell V, Chen IJ, Daechsel JCA, Daniels Z, David L, Dokurno P, Hentzer M, Herzig MC, Hubbard RE, Moore JD, Murray JB, Newland S, Ray SC, Shaw T, Surgenor AE, Terry L, Thirstrup K, Wang Y, Christensen KV.

J Med Chem. 2017 Nov 9;60(21):8945-8962. doi: 10.1021/acs.jmedchem.7b01186. Epub 2017 Oct 27.

PMID:
29023112
13.

It's 10 pm; Do You Know Where Your Data Are? Data Provenance, Curation, and Storage.

Anderson ME, Ray SC.

Circ Res. 2017 May 12;120(10):1551-1554. doi: 10.1161/CIRCRESAHA.116.310424. No abstract available. Erratum in: Circ Res. 2017 Jun 23;121(1):e1.

14.

Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.

Bailey JR, Flyak AI, Cohen VJ, Li H, Wasilewski LN, Snider AE, Wang S, Learn GH, Kose N, Loerinc L, Lampley R, Cox AL, Pfaff JM, Doranz BJ, Shaw GM, Ray SC, Crowe JE Jr.

JCI Insight. 2017 May 4;2(9). pii: 92872. doi: 10.1172/jci.insight.92872. [Epub ahead of print]

15.

Exercise prescription for overhead athletes with shoulder pathology: a systematic review with best evidence synthesis.

Wright AA, Hegedus EJ, Tarara DT, Ray SC, Dischiavi SL.

Br J Sports Med. 2018 Feb;52(4):231-237. doi: 10.1136/bjsports-2016-096915. Epub 2017 Apr 12. Review.

PMID:
28404557
16.

Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.

El-Diwany R, Breitwieser FP, Soliman M, Skaist AM, Srikrishna G, Blankson JN, Ray SC, Wheelan SJ, Thomas DL, Balagopal A.

AIDS. 2017 Jun 19;31(10):1405-1414. doi: 10.1097/QAD.0000000000001480.

17.

Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1.

El-Diwany R, Cohen VJ, Mankowski MC, Wasilewski LN, Brady JK, Snider AE, Osburn WO, Murrell B, Ray SC, Bailey JR.

PLoS Pathog. 2017 Feb 24;13(2):e1006235. doi: 10.1371/journal.ppat.1006235. eCollection 2017 Feb.

18.

Chemical Modification of Graphene Oxide by Nitrogenation: An X-ray Absorption and Emission Spectroscopy Study.

Chuang CH, Ray SC, Mazumder D, Sharma S, Ganguly A, Papakonstantinou P, Chiou JW, Tsai HM, Shiu HW, Chen CH, Lin HJ, Guo J, Pong WF.

Sci Rep. 2017 Feb 10;7:42235. doi: 10.1038/srep42235.

19.

Hepatitis C virus resistance to broadly neutralizing antibodies measured using replication-competent virus and pseudoparticles.

Wasilewski LN, Ray SC, Bailey JR.

J Gen Virol. 2016 Nov;97(11):2883-2893. doi: 10.1099/jgv.0.000608. Epub 2016 Sep 21.

20.

A Hepatitis C Virus Envelope Polymorphism Confers Resistance to Neutralization by Polyclonal Sera and Broadly Neutralizing Monoclonal Antibodies.

Wasilewski LN, El-Diwany R, Munshaw S, Snider AE, Brady JK, Osburn WO, Ray SC, Bailey JR.

J Virol. 2016 Jan 27;90(7):3773-82. doi: 10.1128/JVI.02837-15.

21.

Visualizing chemical states and defects induced magnetism of graphene oxide by spatially-resolved-X-ray microscopy and spectroscopy.

Wang YF, Singh SB, Limaye MV, Shao YC, Hsieh SH, Chen LY, Hsueh HC, Wang HT, Chiou JW, Yeh YC, Chen CW, Chen CH, Ray SC, Wang J, Pong WF, Takagi Y, Ohigashi T, Yokoyama T, Kosugi N.

Sci Rep. 2015 Oct 20;5:15439. doi: 10.1038/srep15439.

22.

Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release.

El-Diwany R, Wasilewski LN, Witwer KW, Bailey JR, Page K, Ray SC, Cox AL, Thomas DL, Balagopal A.

J Virol. 2015 Sep;89(18):9454-64. doi: 10.1128/JVI.00955-15. Epub 2015 Jul 8.

23.

Genome Sequencing and Analysis of Geographically Diverse Clinical Isolates of Herpes Simplex Virus 2.

Newman RM, Lamers SL, Weiner B, Ray SC, Colgrove RC, Diaz F, Jing L, Wang K, Saif S, Young S, Henn M, Laeyendecker O, Tobian AA, Cohen JI, Koelle DM, Quinn TC, Knipe DM.

J Virol. 2015 Aug;89(16):8219-32. doi: 10.1128/JVI.01303-15. Epub 2015 May 27.

24.

Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins.

Lamers SL, Newman RM, Laeyendecker O, Tobian AA, Colgrove RC, Ray SC, Koelle DM, Cohen J, Knipe DM, Quinn TC.

J Virol. 2015 Aug;89(16):8206-18. doi: 10.1128/JVI.01302-15. Epub 2015 May 27.

25.

CD4+ T-Cell-Dependent Reduction in Hepatitis C Virus-Specific Neutralizing Antibody Responses After Coinfection With Human Immunodeficiency Virus.

Bailey JR, Dowd KA, Snider AE, Osburn WO, Mehta SH, Kirk GD, Thomas DL, Ray SC.

J Infect Dis. 2015 Sep 15;212(6):914-23. doi: 10.1093/infdis/jiv139. Epub 2015 Mar 9.

26.

Naturally selected hepatitis C virus polymorphisms confer broad neutralizing antibody resistance.

Bailey JR, Wasilewski LN, Snider AE, El-Diwany R, Osburn WO, Keck Z, Foung SK, Ray SC.

J Clin Invest. 2015 Jan;125(1):437-47. doi: 10.1172/JCI78794. Epub 2014 Dec 15.

27.

Inferring viral dynamics in chronically HCV infected patients from the spatial distribution of infected hepatocytes.

Graw F, Balagopal A, Kandathil AJ, Ray SC, Thomas DL, Ribeiro RM, Perelson AS.

PLoS Comput Biol. 2014 Nov 13;10(11):e1003934. doi: 10.1371/journal.pcbi.1003934. eCollection 2014 Nov.

28.

A root-cause analysis of maternal deaths in Botswana: towards developing a culture of patient safety and quality improvement.

Madzimbamuto FD, Ray SC, Mogobe KD, Ramogola-Masire D, Phillips R, Haverkamp M, Mokotedi M, Motana M.

BMC Pregnancy Childbirth. 2014 Jul 16;14:231. doi: 10.1186/1471-2393-14-231.

29.

The effect of thermal reduction on the photoluminescence and electronic structures of graphene oxides.

Chuang CH, Wang YF, Shao YC, Yeh YC, Wang DY, Chen CW, Chiou JW, Ray SC, Pong WF, Zhang L, Zhu JF, Guo JH.

Sci Rep. 2014 Apr 10;4:4525. doi: 10.1038/srep04525.

30.

Antiretroviral therapy, interferon sensitivity, and virologic setpoint in human immunodeficiency virus/hepatitis C virus coinfected patients.

Balagopal A, Kandathil AJ, Higgins YH, Wood J, Richer J, Quinn J, Eldred L, Li Z, Ray SC, Sulkowski MS, Thomas DL.

Hepatology. 2014 Aug;60(2):477-86. doi: 10.1002/hep.27158. Epub 2014 May 14.

31.

The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models.

Grabowski MK, Lessler J, Redd AD, Kagaayi J, Laeyendecker O, Ndyanabo A, Nelson MI, Cummings DA, Bwanika JB, Mueller AC, Reynolds SJ, Munshaw S, Ray SC, Lutalo T, Manucci J, Tobian AA, Chang LW, Beyrer C, Jennings JM, Nalugoda F, Serwadda D, Wawer MJ, Quinn TC, Gray RH; Rakai Health Sciences Program.

PLoS Med. 2014 Mar 4;11(3):e1001610. doi: 10.1371/journal.pmed.1001610. eCollection 2014 Mar.

32.

Graphene supported graphone/graphane bilayer nanostructure material for spintronics.

Ray SC, Soin N, Makgato T, Chuang CH, Pong WF, Roy SS, Ghosh SK, Strydom AM, McLaughlin JA.

Sci Rep. 2014 Jan 24;4:3862. doi: 10.1038/srep03862.

33.

Clearance of hepatitis C infection is associated with the early appearance of broad neutralizing antibody responses.

Osburn WO, Snider AE, Wells BL, Latanich R, Bailey JR, Thomas DL, Cox AL, Ray SC.

Hepatology. 2014 Jun;59(6):2140-51. doi: 10.1002/hep.27013. Epub 2014 Apr 29.

34.

Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver.

Kandathil AJ, Graw F, Quinn J, Hwang HS, Torbenson M, Perelson AS, Ray SC, Thomas DL, Ribeiro RM, Balagopal A.

Gastroenterology. 2013 Dec;145(6):1404-13.e1-10. doi: 10.1053/j.gastro.2013.08.034. Epub 2013 Aug 22.

35.

Atomistic nucleation sites of Pt nanoparticles on N-doped carbon nanotubes.

Sun CL, Pao CW, Tsai HM, Chiou JW, Ray SC, Wang HW, Hayashi M, Chen LC, Lin HJ, Lee JF, Chang L, Tsai MH, Chen KH, Pong WF.

Nanoscale. 2013 Aug 7;5(15):6812-8. doi: 10.1039/c3nr01234d.

PMID:
23765234
36.

Silicon nanoparticle based fluorescent biological label via low temperature thermal degradation of chloroalkylsilane.

Das P, Saha A, Maity AR, Ray SC, Jana NR.

Nanoscale. 2013 Jul 7;5(13):5732-7. doi: 10.1039/c3nr00932g. Epub 2013 May 28.

PMID:
23715596
37.

Carbon nanoparticle-based fluorescent bioimaging probes.

Bhunia SK, Saha A, Maity AR, Ray SC, Jana NR.

Sci Rep. 2013;3:1473. doi: 10.1038/srep01473.

38.

Thiol-directed synthesis of highly fluorescent gold clusters and their conversion into stable imaging nanoprobes.

Palmal S, Basiruddin SK, Maity AR, Ray SC, Jana NR.

Chemistry. 2013 Jan 14;19(3):943-9. doi: 10.1002/chem.201203083. Epub 2012 Nov 21.

PMID:
23169542
39.

Constraints on viral evolution during chronic hepatitis C virus infection arising from a common-source exposure.

Bailey JR, Laskey S, Wasilewski LN, Munshaw S, Fanning LJ, Kenny-Walsh E, Ray SC.

J Virol. 2012 Dec;86(23):12582-90. doi: 10.1128/JVI.01440-12. Epub 2012 Sep 12.

40.

Expanded function allied dental personnel and dental practice productivity and efficiency.

Beazoglou TJ, Chen L, Lazar VF, Brown LJ, Ray SC, Heffley DR, Berg R, Bailit HL.

J Dent Educ. 2012 Aug;76(8):1054-60.

41.

Immunogenicity and cross-reactivity of a representative ancestral sequence in hepatitis C virus infection.

Burke KP, Munshaw S, Osburn WO, Levine J, Liu L, Sidney J, Sette A, Ray SC, Cox AL.

J Immunol. 2012 May 15;188(10):5177-88. doi: 10.4049/jimmunol.1103008. Epub 2012 Apr 16.

42.

Computational reconstruction of Bole1a, a representative synthetic hepatitis C virus subtype 1a genome.

Munshaw S, Bailey JR, Liu L, Osburn WO, Burke KP, Cox AL, Ray SC.

J Virol. 2012 May;86(10):5915-21. doi: 10.1128/JVI.05959-11. Epub 2012 Mar 21.

43.

Electronic structure, electron field emission and magnetic behaviors of carbon nanotubes fabricated on La0.66Sr0.33MnO3 (LSMO) for spintronics application.

Ray SC, Tsai HM, Chen HC, Wu SL, Ling DC, Lin IN, Pong WF.

J Nanosci Nanotechnol. 2011 Dec;11(12):10710-4.

PMID:
22408979
44.

Laser captured hepatocytes show association of butyrylcholinesterase gene loss and fibrosis progression in hepatitis C-infected drug users.

Munshaw S, Hwang HS, Torbenson M, Quinn J, Hansen KD, Astemborski J, Mehta SH, Ray SC, Thomas DL, Balagopal A.

Hepatology. 2012 Aug;56(2):544-54. doi: 10.1002/hep.25655. Epub 2012 Jul 6.

45.

Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution.

Liu L, Fisher BE, Thomas DL, Cox AL, Ray SC.

Hepatology. 2012 Jun;55(6):1684-91. doi: 10.1002/hep.25575. Epub 2012 Apr 18.

46.

Enhancement of field emission characteristics of carbon nanotubes on oxidation.

Mathur A, Roy SS, Ray SC, Hazra KS, Hamilton J, Dickinson C, McLaughlin J, Misra DS.

J Nanosci Nanotechnol. 2011 Aug;11(8):7011-4.

PMID:
22103114
47.
48.

Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature.

Sabo MC, Luca VC, Ray SC, Bukh J, Fremont DH, Diamond MS.

Virology. 2012 Jan 20;422(2):174-84. doi: 10.1016/j.virol.2011.10.023. Epub 2011 Nov 12.

49.

Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.

Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, Munshaw S, Ray SC, Piwowar-Manning E, McCauley M, Hosseinipour MC, Kumwenda J, Hakim JG, Chariyalertsak S, de Bruyn G, Grinsztejn B, Kumarasamy N, Makhema J, Mayer KH, Pilotto J, Santos BR, Quinn TC, Cohen MS, Hughes JP.

J Infect Dis. 2011 Dec 15;204(12):1918-26. doi: 10.1093/infdis/jir651. Epub 2011 Oct 11.

50.

The transhepatic endotoxin gradient is present despite liver cirrhosis and is attenuated after transjugular portosystemic shunt (TIPS).

Benten D, Schulze zur Wiesch J, Sydow K, Koops A, Buggisch P, Böger RH, Gaydos CA, Won H, Franco V, Lohse AW, Ray SC, Balagopal A.

BMC Gastroenterol. 2011 Oct 6;11:107. doi: 10.1186/1471-230X-11-107.

Supplemental Content

Support Center